Flexible coils with a drug-releasing hydrophilic coating: A new platform for controlled delivery of drugs to the eye?

Journal of Bioactive and Compatible Polymers

Volumn 19, Issue 4, 2004, Pages 267-285

  Pijls, Rachel T ^c   Koole, Leo H ^c   Hanssen, Hans H L ^a   Nuijts, Rudy M M A ^b  

^a MCTec BV   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NONE

Author keywords

Antibiotics release; Drug delivery; Hydrophilic coatings; Mydriasis

Indexed keywords

DIFFUSION; EYE PROTECTION; OPTIMIZATION; PARAMETER ESTIMATION; PLASTIC COATINGS;

EYE DROPS; OPTIMAL DESIGN;

DRUG PRODUCTS;

ATROPINE; CHLORAMPHENICOL; EYE DROPS; FLUORESCEIN; POLYMER;

CONFERENCE PAPER; CONJUNCTIVA; CONTROLLED DRUG RELEASE; DEVICE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; EYE IRRITATION; HUMAN; HUMAN EXPERIMENT; HYDROPHILICITY; LACRIMAL DUCT; LACRIMAL FLUID; LOWER EYELID; MYDRIASIS; NORMAL HUMAN; SLOW DRUG RELEASE;

NASO;

EID: 3242694264     PISSN: 08839115     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883911504045175     Document Type: Conference Paper

References (39)

1. Montdargent, B. and Letrourneur, D. Toward new biomaterials. Infect. Control Hosp. Epidemiol. 21 (2000), 404-410 (Review).
2. Wang, C., Zhang, Q., Uchida, S. and Kodama, M. A new vascular prosthesis coated with polyamino-acid urethane copolymer (PAU) to enhance endothelialization. J. Biomed. Mater. Res. 62 (2002), 315-322.
3. Mueller, X.M., Jegger, D., Augstburger, M., Horisberger, J. and von Segesser, L.K. Poly2-methoxyethylacrylate (PMEA) coated oxygenator: an ex vivo study. Int. J. Artif. Organs 25 (2002), 223-229.
4. Lee, J.H. and Oh, S.H. MMA/MPEOMA/VSA copolymer as a novel blood-compatible material: effect of PEO and negatively charged side chains on protein adsorption and platelet adhesion. J. Biomed. Mater. Res. 60 (2002), 44-52.
5. Court, J.L., Redman, R.P., Wang, J.H., Leppard, S.W., Obyrne, V.J., Small, S.A., Lewis, A.L., Jones, S.A. and Stratford, P.W. A novel phosphorylcholine-coated contact lens for extended wear use. Biomaterials 22 (2001), 3261-3272.
6. Vacheethasanee, K. and Marchant, R.E. Surfactant polymers designed to suppress bacterial (Staphylococcus epidermidis) adhesion on biomaterials. J. Biomed. Mater. Res. 50 (2000), 302-312.
7. Defife, K.M., Hagen, K.M., Clapper, D.L. and Anderson, J.M. Photochemically immobilized polymer coatings: effects on protein adsorption, cell adhesion, and leukocyte activation. J. Biomater. Sci. Polym. Ed. 10 (1999), 1063-1074.
8. Hanssen, J.H.L. and Koole, L.H. Heparin-releasing intravascular guide wires. Med. Device Technol. 13 (2002), 20-22.
9. Prokop, A., Kozlov, E., Nun Non, S., Dikov, M.M., Sephel, G.C., Whitsitt, J.S. and Davidson, J.M. Towards retrievable vascularized bioartificial pancreas: induction and long-lasting stability of polymeric mesh implant vascularized with the help of acidic and basic fibroblast growth factors and hydrogel coating. Diabetes Technol. Ther. 3 (2001), 245-261.
10. Park, S., Bearinger, J.P., Lautenschlager, E.P., Castner, D.G. and Healy, K.E. Surface modification of poly(ethylene terephthalate) angioplasty balloons with a hydrophilic poly(acrylamide-co-ethylene glycol) interpenetrating polymer network coating. J. Biomed. Mater. Res. 53 (2000), 568-576.
11. Altankov, G., Thom, V., Groth, T., Jankova, K., Jonsson, G. and Ulbricht, M. Modulating the biocompatibility of polymer surfaces with poly(ethylene glycol): effect of fibronectin. J. Biomed. Mater. Res. 52 (2000), 219-230.
12. Wieneke, H., Sawitowski, T., Wnendt, S., Fischer, A., Dirsch, O., Karoussos, I.A. and Erbel, R. Stent coating: a new approach in interventional cardiology. Herz 27 (2002), 518-526 (Review).
13. Babapulle, M.N. and Eisenberg, M.J. Coated stents for the prevention of restenosis. Part I. Circulation 106 (2002), 2734-2740. Part II. Circulation 106 (2002), 2859-2866.
14. Babapulle, M.N. and Eisenberg, M.J. Coated stents for the prevention of restenosis. Part I. Circulation 106 (2002), 2734-2740. Part II. Circulation 106 (2002), 2859-2866.
15. Drachman, D.E., Edelman, E.R., Seifert, P., Groothuis, A.R., Bornstein, D.A., Kamath, K.R., Palasis, M., Yang, D., Nott, S.H. and Rogers, C. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J. Am. Coll. Cardiol. 36 (2000), 2325-2332.
16. Sousa, J.E., Costa, M.A., Sousa, A.G., Abizaid, A.C., Seixas, A.C., Abizaid, A.S., Feres, F., Mattos, L.A., Falotico, R., Jaeger, J., Popma J.J. and Serruys, P.W. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 107 (2003), 381-383.
17. Drachman, D.E. Clinical experience with drug-eluting stents. Rev. Cardiovasc. Med. 3 (2002), S31-37 (Review).
18. Morice, M.C. A new era in the treatment of coronary disease? Eur. Heart J. 24 (2003), 209-211.
19. Hanssen, J.H.L., Wetzels, G.M., Benzina, A., van der Veen, F.H., Lindhout, T. and Koole, L.H. Metallic wires with an adherent lubricious and blood-compatible polymeric coating and their use in the manufacture of novel slippery-when-wet guide wires: possible applications related to controlled local drug delivery. J. Biomed. Mater. Res. 48 (1999), 820-828.
20. Peerlings, C.C., Hanssen, J.H.L., Bevers, R.T., Boelen, E.J., Stelt, B.J., Korthagen, E.J. and Koole, L.H. Heparin release from slippery-when-wet guide wires for intravascular use. J. Biomed. Mater. Res. 63 (2002), 692-698.
21. Aldenhoff, Y.B.J., Knetsch, M.L.W., Hanssen, J.H., Lindhout, T., Wielders, S.J. and Koole, L.H. Coils and tubes releasing heparin. Studies on a new vascular graft prototype. Biomaterials 25 (2004), 3125-3133.
22. Merck Index, Merck & Co., Inc. (Rahway, NJ, USA), 11th edn., 1989, entry # 891, p. 138. See also: A.A. al-Badr and F.J. Muhtadi. In: Analytical Profiles of Drug Substances, Vol. 14, K. Flory, Ed., Academic Press (New York, NY, USA), pp. 325-389 (1985).
23. Merck Index, Merck & Co., Inc. (Rahway, NJ, USA), 11th edn., 1989, entry # 891, p. 138. See also: A.A. al-Badr and F.J. Muhtadi. In: Analytical Profiles of Drug Substances, Vol. 14, K. Flory, Ed., Academic Press (New York, NY, USA), pp. 325-389 (1985).
24. Merck Index, Merck & Co., Inc. (Rahway, NJ, USA), 11th Edn, 1989, entry # 2068, p. 318. See also: Shalit, I. and Marks, M.I. Drugs 28 (1984), 281-291.
25. Merck Index, Merck & Co., Inc. (Rahway, NJ, USA), 11th Edn, 1989, entry # 2068, p. 318. See also: Shalit, I. and Marks, M.I. Drugs 28 (1984), 281-291.
26. Bawa, R. In: Ophthalmic Drug Delivery Systems, Marcel Dekker Inc. (New York, NY, USA), A.K. Mitra, Ed., pp. 223-259 (1993).
27. Richardson, M.C. and Bentley, P.H. In: Ophthalmic Drug Delivery Systems, Marcel Dekker Inc. (New York, NY, USA), A.K. Mitra, Ed., pp. 355-367 (1993).
28. Chien, Y.W. In: Novel Drug Delivery Systems, Marcel Dekker Inc. (New York, NY, USA), pp. 13-50 (1982).
29. Shell, J.W. and Baker, R.W. Diffusional systems for controlled release of drugs to the eye. Ann. Ophthalmol. 6 (1974), 1037-1045.
30. Leydhecker, W. Ocusert, summary of a round-table discussion. Klin. Monatsbl. Augenheilk. 6 (1975), 917-8.
31. Bloomfield, S.E., Miyata, T., Dunn, M.W., Bueser, N., Stenzel, K.H. and Rubin, A.L. Soluble gentamicin ophthalmic inserts as a drug delivery system. Arch. Ophthalm. 96 (1978), 885-887.
32. Katz, I.M. and Blackmann, W.M. A soluble sustained release ophthalmic delivery unit. Am. J. Ophthalm. 83 (1977), 728-734.
33. Saettone, M.F. and Salminen, L. Ocular inserts for topical delivery. Adv. Drug Deliv. Rev. 16 (1995), 95-106.
34. Aiache, J.-M., el Meski, S., Serpin, G., Beyssac, E. and Conti, R. Local tolerance and in vivo release study of a new ocular drug delivery system. Drug Deliv. Systems & Sciences 2 (2002), 85-88.
35. Lee, Y.-C., Millard, J.W., Negvesky, G.J., Butrus, S.I. and Yalkowski, S.H. Formulation and in vivo evaluation of an ocular insert containing phenylephrine and tropicamine. Int. J. Pharm. 182 (1999), 121-126.
36. Sasaki, H., Nagano, T., Sakanaka, K., Kawakami, S., Nishida, K., Nakamura, J., Ichikawa, N., Nakamura, T. and Nashima, M. One-sided insert as a unique ophthalmic drug delivery system. J. Contr. Release 92 (2003), 241-247.
37. Hornof, M., Weyenberg, W., Ludwig, A. and Bernkop-Schnurch, A. Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans. J. Contr. Release 89 (2003), 419-428.
38. Ceulemans, J., Vermaire, A., Adriaens, E., Remon, J.P. and Ludwig, A. Evaluation of a mucoadhesive tablet for ocular use. J. Contr. Release 77 (2001), 333-344.
39. Balasubramaniam, J. and Pandit, J.K. Ion-activated in situ gelling systems for sustained ophthalmic delivery of cyprofloxacin hydrochloride. Drug Deliv. 10 (2003), 185-191.